Express

Leading Pharmaceutical Biotechnology Soars Nearly 240% Intraday, Announces Plan to Acquire Conflux

Summary: Leading Pharmaceutical Biotechnology, a Hong Kong-listed company, surged significantly in early trading today, rising nearly 240% at one point before narrowing gains. The stock price reached 0.7 Hong Kong dollars before retreating to around 0.34 Hong Kong dollars. The company had previously announced plans to acquire all shares of Conflux to expand into the blockchain ...

Leading Pharmaceutical Biotechnology, a Hong Kong-listed company, surged significantly in early trading today, rising nearly 240% at one point before narrowing gains. The stock price reached 0.7 Hong Kong dollars before retreating to around 0.34 Hong Kong dollars. The company had previously announced plans to acquire all shares of Conflux to expand into the blockchain sector, with two founding members of Conflux serving as its executive directors.

Last Update:

Tags:
Link: Leading Pharmaceutical Biotechnology Soars Nearly 240% Intraday, Announces Plan to Acquire Conflux [Copy]

Last: 1RT Acquisition Corp. Plans to Raise $150 Million Through IPO to Expand Digital Assets, Fintech Business

Next: Analysis: Strengthening Cooperation between Hong Kong and Shanghai to Form a Positive Development Pattern for Onshore Digital RMB and Offshore RMB Stablecoins

Trump's "Big and Beautiful" Bill Passes: Biden and Harris Criticize, Financial Expert O... 17 hours ago

Silicon Valley Giants, Trump Ally Launch 'Crypto Bank' Erebor, Aiming to Fill SVB Void 2 days ago

From Data Rights to Digital Property: Whistleblower Brittany Kaiser on Blockchain, RWA,... 8 days ago

The Base Chain's Ascent: How Deep Coinbase Integration and JPMorgan's Pilot Are Reshapi... 14 days ago

Tether in Trouble? U.S. Senate Just Passed a Law That Could Dethrone the $155B Stableco... 17 days ago